Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small-cell Lung”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00385164
What this trial is testing

The Utility of FDG-PET for Radiation Treatment in NSCLC

Who this might be right for
Lung NeoplasmsPositron Emission Tomography
AHS Cancer Control Alberta 50
Very early researchEnded earlyNCT01261299
What this trial is testing

Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungUrinary Bladder Neoplasms
University of California, Davis 21
Not applicableStudy completedNCT07243899
What this trial is testing

Multimodal Model Predicts Treatment Efficacy and CIP Risk in Advanced NSCLC With Immunotherapy and Chemotherapy

Who this might be right for
NSCLC
Shanghai Zhongshan Hospital 3,000
Testing effectiveness (Phase 2)Looking for participantsNCT07070232
What this trial is testing

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Who this might be right for
Advanced Solid Tumor
BioNTech SE 1,438
Testing effectiveness (Phase 2)UnknownNCT04903873
What this trial is testing

Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

Who this might be right for
Solid TumorRenal Cell Cancer MetastaticNon-Small Cell Lung Cancer+2 more
Eutilex 110
Testing effectiveness (Phase 2)Ended earlyNCT03737994
What this trial is testing

Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer

Who this might be right for
Lung Non-Squamous Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8+1 more
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)WithdrawnNCT07353957
What this trial is testing

Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer - Non Small Cell SquamousLung Cancer - Non Small Cell Non-Squamous
Merus B.V.
Early research (Phase 1)UnknownNCT00062907
What this trial is testing

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Corixa Corporation 9
Testing effectiveness (Phase 2)UnknownNCT00616499
What this trial is testing

Gefitinib in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Yonsei University 35
Early research (Phase 1)Study completedNCT00471432
What this trial is testing

OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors

Who this might be right for
Bladder CancerBreast CancerKidney Cancer+4 more
NCIC Clinical Trials Group 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03647163
What this trial is testing

Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors

Who this might be right for
Solid TumorNon Small Cell Lung CancerNeuroendocrine Carcinoma+1 more
Vyriad, Inc. 33
Testing effectiveness (Phase 2)Looking for participantsNCT07670312
What this trial is testing

Evaluation of XYA02 in Patients With Advanced Solid Tumors

Who this might be right for
MUC1-expressing Advanced, Relapsed and/or Refractory Solid TumorsNon-Small Cell Lung CancerOvarian Cancer+4 more
XYone Therapeutics, Inc 190
Testing effectiveness (Phase 2)UnknownNCT02223611
What this trial is testing

Clinical Observation of S1 Capsule for Stage Ⅱ-ⅢA Non-small Cell Lung Cancer After Complete Resection

Who this might be right for
Non-small Cell Lung Cancer Stage ⅡNon-small Cell Lung Cancer Stage ⅢA
Hebei Medical University Fourth Hospital 100
Testing effectiveness (Phase 2)WithdrawnNCT00048087
What this trial is testing

Iressa/Docetaxel in Non-Small-Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT03215693
What this trial is testing

X-396 Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib

Who this might be right for
Non-Small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 152
Early research (Phase 1)Study completedNCT01460134
What this trial is testing

CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Who this might be right for
CD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more
Celldex Therapeutics 90
Not applicableStudy completedNCT05348187
What this trial is testing

Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit

Who this might be right for
Non-Small Cell Lung CancerColorectal Cancer
QIAGEN Gaithersburg, Inc 309
Testing effectiveness (Phase 2)Study completedNCT04900363
What this trial is testing

A Trial of AK112 (PD-1/VEGF Bispecific Antibody) in Patients With NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Akeso 108
Not applicableUnknownNCT02648087
What this trial is testing

Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer

Who this might be right for
Bronchial Cancer
University Hospital, Angers 1,200
Early research (Phase 1)Looking for participantsNCT07130916
What this trial is testing

Aumolertinib in European Participants With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. 20
Next Page